Details for 2016724387

Up to date per 04.04.2026

Actions

Title / Product Name

KRISTALLINE FORM DER VERBINDUNG (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPAN-1,2-DIOL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016724387

EP Publication Number

3298008

E-Number

1204092

Language

PCT Number

EP16061200

Publication Date

28.03.2018 A

20.11.2019 B1

Registration Date

20.11.2019

AT Publication Date

15.12.2019

Application Date

19.05.2016

Registration Number

Priorities

20.05.2015

PCT/EP2015/061153

IPC

C07D 413/04 20060101AFI20161130BHEP

Maximum Duration of Protection

19.05.2036

Owner

Viatris Asia Pacific Pte. Ltd.2 Shenton Way, #18-01, SGX Centre 1 Singapur 068804SG

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

LESCOP, Cyrillec/o Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 4123 AllschwilCH

Information about Fees